Quarterly report pursuant to Section 13 or 15(d)

Schedule of Dilutive Effect of Various Potential Common Shares (Details)

v3.21.2
Schedule of Dilutive Effect of Various Potential Common Shares (Details) - shares
 1 Months Ended 6 Months Ended
Aug. 02, 2021
Aug. 11, 2021
Jun. 30, 2021
Jun. 30, 2020
Subsequent Event [Line Items]        
Total dilutive potential common shares, including outstanding common stock     214,211,788 81,802
Convertible Preferred Stock [Member]        
Subsequent Event [Line Items]        
Total dilutive potential common shares, including outstanding common stock     85,852,763 16,761
Warrant [Member]        
Subsequent Event [Line Items]        
Total dilutive potential common shares, including outstanding common stock     122,395,632 63,467
Share-based Payment Arrangement, Option [Member]        
Subsequent Event [Line Items]        
Total dilutive potential common shares, including outstanding common stock     26 26
Subsequent Event [Member]        
Subsequent Event [Line Items]        
Total dilutive potential common shares, including outstanding common stock 4,700,000,000 4,697,806,840    
Subsequent Event [Member] | Common Shares Outstanding [Member]        
Subsequent Event [Line Items]        
Total dilutive potential common shares, including outstanding common stock   29,350,000    
Subsequent Event [Member] | Convertible Preferred Stock [Member]        
Subsequent Event [Line Items]        
Total dilutive potential common shares, including outstanding common stock   1,775,720,879    
Subsequent Event [Member] | Warrant [Member]        
Subsequent Event [Line Items]        
Total dilutive potential common shares, including outstanding common stock   2,657,130,516    
Subsequent Event [Member] | Convertible Debt [Member]        
Subsequent Event [Line Items]        
Total dilutive potential common shares, including outstanding common stock   235,605,419    
Subsequent Event [Member] | Share-based Payment Arrangement, Option [Member]        
Subsequent Event [Line Items]        
Total dilutive potential common shares, including outstanding common stock   26